A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection

International Journal of Colorectal Disease

Volumn 26, Issue 5, 2011, Pages 583-592

  Kalimutho, Murugan ^a,c   Del Vecchio Blanco, Giovanna ^a,b   Cretella, Micaela ^b   Mannisi, Elena ^b   Sileri, Pierpaolo ^b   Formosa, Amanda ^a   Pallone, Francesco ^a,b   Federici, Giorgio ^a,b   Bernardini, Sergio ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

CRC; DIA; Feces; iFOBT; L DNA; QdHPLC DIA

Indexed keywords

APC PROTEIN; B RAF KINASE; BETA ACTIN; CALGRANULIN; K RAS PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DEGRADATION; DNA INTEGRATION; DYSPLASIA; FALSE POSITIVE RESULT; FECES ANALYSIS; FEMALE; GENE AMPLIFICATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA; FECES; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; NUCLEIC ACID DENATURATION; OCCULT BLOOD; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 79956105764     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-010-1128-x     Document Type: Article

References (36)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E et al (2004) Cancer statistics. CA Cancer J Clin 54:8-29
2. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, Fric P (2009) Colorectal cancer screening in Europe. World J Gastroenterol 21:5907-5915
3. Walsh JM, Terdiman JP (2003) Colorectal cancer screening: scientific review. JAMA 289:1288-1296 (Pubitemid 37432910)
4. Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennal screening for fecal occult blood. J Natl Cancer Inst 91:434-437 (Pubitemid 29128279)
5. Mande JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F, The Minnesota Colon Cancer Control Study (1993) Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 328 (19):1365-71
6. Ahlquist D, Shuber AP (2002) Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin Chim Acta 315:157-168 (Pubitemid 33145255)
7. Cole SR, Young GP (1999) Dietary restriction impairs compliance with FOB screening for colorectal cancer. Gastroenterology 116:A391
8. Ahlquist DA, McGill DB, Fleming JL, Schwartz S, Wieand HS, Rubin J, Moertel CG (1089) Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 63:1826-1830
9. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S et al (2007) Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 56:210-214
10. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E et al (2007) A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 146:244-255 (Pubitemid 351650610)
11. Levi Z, Hazazi R, Rozen P, Vilkin A, Waked A, Niv Y (2006) A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Aliment Pharmacol Ther 23:1359-1364
12. Limburg PJ, Devens ME, Harrington JJ, Diehl NN, Mahoney DW, Ahlquist DA (2003) Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia. AMJ Gastroenterol 98:2299-2305 (Pubitemid 37305374)
13. Kronborg O, Ugstad M, Fuglerud P, Johne B, Hardcastle J, Scholefield JH et al (2000) Faecal calprotectin levels in a high risk population for colorectal neoplasia. Gut 46:795-800 (Pubitemid 30329073)
14. Tibble J, Sigthorsson G, Foster R, Sherwood R, Fagerhol M, Bjarnason I (2001) Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut 49:402-408 (Pubitemid 32802576)
15. Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH (2004) Testing for faecal calprotectin (PhiCal) in the Norwegian colorectal cancer prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Gut 53:1329-1333
16. Røseth AG, Fagerhol MK, Aadland E, Schjønsby H (1992) Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 27:793-798
17. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B (1992) Identification of ras oncogene mutations in the stool of patient with curable colorectal tumors. Science 256:102-105
18. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ (2002) Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346:311-320 (Pubitemid 34438838)
19. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP BGC, Giardiello FM et al (1995) Inhibition of apoptosis during developments of colorectal cancer. Cancer Res 55:1811-1816
20. Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE et al (2000) Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119:1219-1227
21. Boynton KA, Summerhayes IC, Ahlquist DA, Shuber AP (2003) DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clin Chem 49:1058-1065 (Pubitemid 36751091)
22. Kalimutho M, Blanco GD, Gravina P, Cretella M, Mannucci L, Mannisi E et al (2010) Quantitative Denaturing high performance liquid chromatography (dHPLC) detection of APC Long DNA and mutations in faeces from colorectal cancer patients. Clin Chem Lab Med 48(9):1303-1311
23. Abbaszadegan MR, Tavasoli A, Velayati A, Sima HR, Vosooghinia H, Farzadnia M et al (2007) Stool-based DNA testing a new non invasive method for colorectal cancer screening, the first report from Iran. World J Gastroenterol 13:1528-1533 (Pubitemid 46672660)
24. Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L et al (2008) A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol 103:2862-2870
25. Kim Y, Lee S, Park S, Jeon H, Lee W, Kim JK et al (2003) Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. Ann Clin Lab Sci 33:32-38 (Pubitemid 36336997)
26. Pucci S, Bonanno E, Sesti F, Mazzarelli P, Mauriello A, Ricci F et al (2009) Clusterin in stool: a new biomarker for colon cancer screening? Am J Gastroenterol 104:2807-2815
27. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, Colorectal Cancer Study Group (2004) Fecal DNA versus fecal occult blood for colorectal cancer screening in an average-risk population. N Engl J Med 351:2704-2714
28. Booth A (2007) Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett 249:87-96
29. Loktionov A, O'Neill IK, Silvester KR, Cummings JH, Middleton SJ, Miller R (1998) Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin Cancer Res 4:337-342 (Pubitemid 28122747)
30. Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE (2005) Non invasive testing for colorectal cancer. A review. J Gastroenterol 100:1393-1403 (Pubitemid 40904368)
31. Røseth AG, Kristinsson J, Fagerhol MK, Schjønsby H, Aadland E, Nygaard K, Roald B (1993) Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 28:1073-1076
32. Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, Loprinzi CL et al (2009) High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology 136:459-470
33. Lai LP, Su YN, Hsieh FJ, Chiang FT, Juang JM, Liu YB et al (2005) Denaturing high-performance liquid chromatography screening of the long QT syndrome-related cardiac sodium and potassium channel genes and identification of novel mutations and single nucleotide polymorphisms. J Hum Genet 50:490-496
34. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
35. Calistri D, Rengucci C, Lattuneddu A, Francioni G, Polifemo AM, Nanni O et al (2004) Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool. Neoplasia 6:536-540 (Pubitemid 39411090)
36. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845